Early-stage investor Syncona readjusts priorities due to bleak biotech marketnews2025-06-20T14:17:08+00:00June 20th, 2025|Endpoints News|
Draig Therapeutics unveils $140M Series A for neuropsychiatry pipelinenews2025-06-18T04:00:39+00:00June 18th, 2025|Endpoints News|
Endpoints 11 nominations: Help us find 2025’s best biotech startupsnews2025-06-16T13:56:22+00:00June 16th, 2025|Endpoints News|
Commons Clinic raises $26M Series B to offer preventive testingnews2025-06-12T13:00:29+00:00June 12th, 2025|Endpoints News|
Organoid startup raises $21M to test drugs and vaccines in human lymph nodes-in-a-dishnews2025-06-11T19:38:11+00:00June 11th, 2025|Endpoints News|
Novo marks seventh cardiometabolic deal of the year with Deep Apple Therapeuticsnews2025-06-11T11:00:15+00:00June 11th, 2025|Endpoints News|
SpliceBio gets $135M shortly after starting first clinical trialnews2025-06-11T07:00:58+00:00June 11th, 2025|Endpoints News|
Exclusive: Post-Lilly deal, Scorpion crew carries on with $177M at Antaresnews2025-06-10T12:00:53+00:00June 10th, 2025|Endpoints News|
Odyssey Therapeutics withdraws IPO plans as public markets remain frozennews2025-06-10T09:00:18+00:00June 10th, 2025|Endpoints News|
Metsera shares early data on anti-obesity amylin candidatenews2025-06-09T11:00:52+00:00June 9th, 2025|Endpoints News|
